M. Hatsuse

发表

ADAMTS‐13 activity can predict the outcome of disseminated intravascular coagulation in hematologic malignancies treated with recombinant human soluble thrombomodulin

M. Taniwaki, H. Kaneko, S. Horiike, 2012, American journal of hematology.

A newly developed bisphosphonate, YM529, is a potent apoptosis inducer of human myeloma cells.

H. Hirai, E. Ashihara, M. Nakagawa, 2001, Leukemia research.

Effect of vinorelbine on the growth of human myeloma cell lines in vitro.

H. Hirai, E. Ashihara, M. Nakagawa, 2002, Leukemia research.

The longitudinal analysis of large granular lymphocytosis in patients with Philadelphia chromosome-positive leukemia treated with dasatinib

M. Taniwaki, H. Kaneko, S. Horiike, 2015, International Journal of Hematology.

Combination of lenalidomide and low-dose dexamethasone therapy promotes the anticoagulant activity of warfarin in patients with immunoglobulin light-chain amyloidosis.

K. Takara, Y. Nakayama, C. Shimazaki, 2017, Oncology letters.

CD34+/CD90+ cells infused best predict late haematopoietic reconstitution following autologous peripheral blood stem cell transplantation

E. Ashihara, M. Nakagawa, C. Shimazaki, 2002, British journal of haematology.

Immunosuppressive therapy with rabbit antithymocyte globulin therapy for acquired aplastic anemia: a multi-institutional retrospective study in Japanese adult patients

M. Taniwaki, H. Kaneko, J. Kuroda, 2019, International Journal of Hematology.

Clinical characteristics of B-cell lymphoma-associated hemophagocytic syndrome (B-LAHS): comparison of CD5+ with CD5- B-LAHS.

E. Ashihara, M. Nakagawa, C. Shimazaki, 2001, Internal medicine.

The response to second-line induction with bortezomib and dexamethasone is predictive of long-term outcomes prior to high-dose chemotherapy with autologous stem cell transplantation for multiple myeloma.

M. Taniwaki, H. Kaneko, S. Horiike, 2013, Internal medicine.

The interaction between oral melphalan and gastric antisecretory drugs: Impact on clinical efficacy and toxicity.

K. Takara, Y. Nakayama, C. Shimazaki, 2016, Molecular and clinical oncology.

Clinicopathological features of myeloid/natural killer (NK) cell precursor acute leukemia.

E. Ashihara, M. Nakagawa, C. Shimazaki, 2001, Leukemia research.

Rhabdophis tigrinus IN JAPAN: PATHOGENESIS OF ENVENOMATION AND PRODUCTION OF ANTIVENOM

A. Saki, M. Hatsuse, Y. Sawai, 2002 .

Booster transplantation for a MDS patient to improve poor graft function after allogeneic transplantation

C. Shimazaki, S. Murakami, A. Okano, 2017 .

Pharmacokinetic Interaction Between Tacrolimus and Fentanyl in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation.

K. Takara, Y. Nakayama, C. Shimazaki, 2017, Annals of transplantation.

Infusion of a high number of CD34+ cells provides a rapid hematopoietic recovery and cost savings in autologous peripheral blood stem cell transplantation.

E. Ashihara, M. Nakagawa, C. Shimazaki, 2002, Japanese journal of clinical oncology.

Autologous peripheral blood stem cell transplantation for adult patients with B-cell lymphoma-associated hemophagocytic syndrome

E. Ashihara, M. Nakagawa, C. Shimazaki, 2001, Leukemia.

A retrospective analysis of treatment outcomes in 45 patients with cardiac light-chain amyloidosis: a single-center experience in Japan

N. Maruyama, Daisuke Ide, C. Shimazaki, 2020, International Journal of Hematology.

Combination Therapy with Thalidomide, Incadronate, and Dexamethasone for Relapsed or Refractory Multiple Myeloma

E. Ashihara, C. Shimazaki, A. Okano, 2005, International Journal of Hematology.

Serial measurement of free light chain detects poor response to therapy early in three patients with multiple myeloma who have measurable M-proteins

C. Shimazaki, S. Murakami, A. Okano, 2012, International Journal of Hematology.

Subcutaneous infection with Mycobacterium fortuitum after allogeneic bone marrow transplantation

Y. Noda, E. Ashihara, M. Nakagawa, 2001, Bone Marrow Transplantation.

Serological change of Hepatitis B virus (HBV) markers in a patient with myelodysplastic syndrome showing HBV reactivation after allogeneic hematopoietic stem cell transplantation

C. Shimazaki, S. Murakami, A. Okano, 2017 .

[REACTIVATION OF TUBERCULOSIS PRESENTING WITH EMPYEMA DUE TO ANTICANCER CHEMOTHERAPY FOR DIFFUSE LARGE B CELL LYMPHOMA].

T. Yuba, A. Yoshimura, M. Hatsuse, 2016, Kekkaku : [Tuberculosis].

Early Relapse After High-Dose Chemotherapy Rescued by Tumor-Free Autologous Peripheral Blood Stem Cells in Acute Lymphoblastic Leukemia: Importance of Monitoring for WT1-mRNA Quantitatively

K. Nakahara, E. Ashihara, M. Nakagawa, 2001, Leukemia & lymphoma.

Plasma thrombopoietin levels in Sebastian platelet syndrome

E. Ashihara, M. Nakagawa, C. Shimazaki, 2001, European journal of haematology.

Bortezomib plus dexamethasone for relapsed or treatment refractory multiple myeloma: the collaborative study at six institutes in Kyoto and Osaka

M. Taniwaki, H. Kaneko, S. Horiike, 2010, International journal of hematology.

Prediction of the Lenalidomide Toxicity and Its Therapeutic Efficacy in Japanese Multiple Myeloma Patients By Measuring Its Plasma Concentration.

K. Nishiguchi, T. Minegaki, M. Tsujimoto, 2015 .

Meningeal Relapse after Double Peripheral Blood Stem Cell Transplantation in IgD Myeloma

H. Hirai, E. Ashihara, M. Nakagawa, 2002, Leukemia & lymphoma.

Expression of T‐cell‐associated antigens in B‐cell non‐Hodgkin's lymphoma

E. Ashihara, M. Nakagawa, S. Hibi, 2000, British journal of haematology.

The serum level of plasmin‐alpha2 plasmin inhibitor complex (PIC) is useful for differentiating cardiac light chain amyloidosis from transthyretin amyloidosis

C. Shimazaki, M. Hatsuse, S. Fuchida, 2023, British journal of haematology.

J. Yasuda, E. Ashihara, M. Nakagawa, 2001, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Factors Associated with Dose Modification of Lenalidomide Plus Dexamethasone Therapy in Multiple Myeloma.

K. Nishiguchi, T. Minegaki, M. Tsujimoto, 2020, Biological & pharmaceutical bulletin.